SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PSDV - pSivida Limited
PSDV 1.220+14.0%Mar 29 4:00 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: John McCarthy4/23/2012 11:03:56 AM
   of 421
 
Buyout speculation .....

SeekingAlpha

SNIP

I find the above information very interesting considering the small market cap of roughly $45M for pSivida. The commitment potential after phase II is over three times the entire market cap. At a 125% premium, pSivida can be had for a bit over $100M, or around $5 a share. However, smaller cap companies like pSivida often carry a higher premium, so up to 200% in my opinion is not out of the question.

seekingalpha.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext